A registry-based, observational safety study of inotuzumab ozogamicin (InO) treatment in patients (pts) with B-cell precursor acute lymphoblastic leukemia (ALL) who proceeded to hematopoietic stem cell transplant (HSCT) Meeting Abstract

  

Authors:	De Lima, M. J. G.; Kebriaei, P.; Lanza, F.; Cho, C.; Giralt, S.; Popradi, G.; Hemmer, M. T.; Zhang, X.; Shah, R.; Welch, V. L.; Vandendries, E.; Stelljes, M.; Marks, D. I.; Saber, W.
Abstract Title:	A registry-based, observational safety study of inotuzumab ozogamicin (InO) treatment in patients (pts) with B-cell precursor acute lymphoblastic leukemia (ALL) who proceeded to hematopoietic stem cell transplant (HSCT)
Meeting Title:	2021 ASCO Annual Meeting
Journal Title:	Journal of Clinical Oncology
Volume:	39
Issue:	15 Suppl.
Meeting Dates:	2021 Jun 4-8
Meeting Location:	Virtual
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2021-05-20
Language:	English
ACCESSION:	WOS:000708120604065
DOI:	10.1200/JCO.2021.39.15_suppl.7017
PROVIDER:	wos
Notes:	Meeting Abstract: 7017 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/191258